A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...

So when my urologist said in 2019 that my PSA test showed the most aggressive form of prostate cancer, I was not prepared. I was 68, and my annual tests had always been normal. Soon I embarked on a ...

Male hormones, including testosterone, are called androgens, and treatment to shut down male hormones is known as androgen deprivation therapy, or ADT. Almost all men initially respond, sometimes ...

When we use androgen deprivation therapy, we are lowering testosterone levels typically by turning off the testes from making testosterone. This starves cancer cells, causing them to shut down, ...

Drs Sandhya Srinivas and Rana R. McKay discuss bone health and survivorship, including risk factors and potential side effects with androgen deprivation therapy in patients with prostate cancer.

CORRESPONDENCE June 01, 2018 Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer Authors: Carlo Cattrini [email protected], Elisa Zanardi, and Francesco ...

Hormone therapy for prostate cancer is associated with an increased risk for dementia, a new study has found. Androgen deprivation therapy, or A.D.T., is used to treat prostate cancer of varying ...

Levine GN, D'Amico AV, Berger P, et al. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and ...

Androgen deprivation therapy (ADT) for prostate cancer is associated with decreased bone mineral density (BMD) in patients. This decreased BMD can lead to an increased risk of fractures and ...

To the Editor: In their article on the use of short-term androgen-deprivation therapy (ADT) before and during radiotherapy in patients with localized prostate cancer, Jones et al. (July 14 issue)1 ...

Androgen deprivation therapy is commonly used to treat prostate cancer, often on an open-ended basis for therapy of advanced prostate cancer. It is estimated that 44 percent of men with prostate ...